SU749364A3 - Способ получени лактонов - Google Patents

Способ получени лактонов Download PDF

Info

Publication number
SU749364A3
SU749364A3 SU772480801A SU2480801A SU749364A3 SU 749364 A3 SU749364 A3 SU 749364A3 SU 772480801 A SU772480801 A SU 772480801A SU 2480801 A SU2480801 A SU 2480801A SU 749364 A3 SU749364 A3 SU 749364A3
Authority
SU
USSR - Soviet Union
Prior art keywords
hydroxy
acid
solution
product
ethyl acetate
Prior art date
Application number
SU772480801A
Other languages
English (en)
Russian (ru)
Inventor
Бюандиа Жан
Вива Мишель
Original Assignee
Руссель-Юклаф (Фирма)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Руссель-Юклаф (Фирма) filed Critical Руссель-Юклаф (Фирма)
Application granted granted Critical
Publication of SU749364A3 publication Critical patent/SU749364A3/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • C07D213/82Amides; Imides in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/94Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SU772480801A 1976-03-19 1977-03-18 Способ получени лактонов SU749364A3 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7608004A FR2344285A1 (fr) 1976-03-19 1976-03-19 Nouvelles lactones derivees du cyclopentanol, leur procede de preparation et leur application comme medicaments

Publications (1)

Publication Number Publication Date
SU749364A3 true SU749364A3 (ru) 1980-07-15

Family

ID=9170682

Family Applications (2)

Application Number Title Priority Date Filing Date
SU772480801A SU749364A3 (ru) 1976-03-19 1977-03-18 Способ получени лактонов
SU782623757A SU745366A3 (ru) 1976-03-19 1978-06-08 Способ получени лактона циклопентанкарбоновой кислоты

Family Applications After (1)

Application Number Title Priority Date Filing Date
SU782623757A SU745366A3 (ru) 1976-03-19 1978-06-08 Способ получени лактона циклопентанкарбоновой кислоты

Country Status (20)

Country Link
JP (1) JPS52113956A (xx)
AT (1) AT357275B (xx)
AU (1) AU506760B2 (xx)
BE (1) BE852624A (xx)
CA (1) CA1094569A (xx)
CH (1) CH620688A5 (xx)
DE (1) DE2711950A1 (xx)
DK (1) DK119377A (xx)
ES (1) ES456999A1 (xx)
FR (1) FR2344285A1 (xx)
GB (1) GB1538717A (xx)
HU (1) HU178332B (xx)
IE (1) IE45124B1 (xx)
IL (1) IL51690A (xx)
LU (1) LU76976A1 (xx)
NL (1) NL7703056A (xx)
PT (1) PT66326B (xx)
SE (1) SE436877B (xx)
SU (2) SU749364A3 (xx)
ZA (1) ZA771654B (xx)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2540330C2 (ru) * 2009-07-28 2015-02-10 Оно Фармасьютикал Ко., Лтд. Бициклическое соединение и его применение для медицинских целей

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2439779A2 (fr) * 1976-03-19 1980-05-23 Roussel Uclaf Nouvelles lactones derivees du cyclopentanol, leur procede de preparation et leur application comme medicaments
FR2443466A1 (fr) * 1978-12-05 1980-07-04 Roussel Uclaf Nouvelles b-lactones derivees de l'acide 2-hydroxy cyclopentane carboxylique, leur procede de preparation et leur application comme medicaments
DE3722133A1 (de) * 1987-07-04 1989-01-12 Bayer Ag Azolyl-tetrahydropyran-derivate
EP1142886A1 (en) 2000-04-07 2001-10-10 Aventis Pharma Deutschland GmbH Percyquinnin, a process for its production and its use as a pharmaceutical
CN100417650C (zh) * 2006-08-17 2008-09-10 中国科学院昆明植物研究所 韧革菌素及其制备方法和在药物上的应用

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2540330C2 (ru) * 2009-07-28 2015-02-10 Оно Фармасьютикал Ко., Лтд. Бициклическое соединение и его применение для медицинских целей

Also Published As

Publication number Publication date
ES456999A1 (es) 1978-01-16
ATA195077A (de) 1979-11-15
IE45124B1 (en) 1982-06-30
AU2346677A (en) 1978-09-28
HU178332B (en) 1982-04-28
FR2344285B1 (xx) 1979-02-02
IL51690A (en) 1982-02-28
CA1094569A (fr) 1981-01-27
IE45124L (en) 1977-09-19
GB1538717A (en) 1979-01-24
JPS62146B2 (xx) 1987-01-06
PT66326A (fr) 1977-04-01
NL7703056A (nl) 1977-09-21
CH620688A5 (en) 1980-12-15
JPS52113956A (en) 1977-09-24
AU506760B2 (en) 1980-01-24
SU745366A3 (ru) 1980-06-30
DE2711950A1 (de) 1977-09-29
SE436877B (sv) 1985-01-28
FR2344285A1 (fr) 1977-10-14
IL51690A0 (en) 1977-05-31
BE852624A (fr) 1977-09-19
ZA771654B (en) 1978-04-26
AT357275B (de) 1980-06-25
PT66326B (pt) 1979-01-18
DK119377A (da) 1977-09-20
SE7702908L (sv) 1977-09-20
LU76976A1 (xx) 1977-10-03

Similar Documents

Publication Publication Date Title
Cornforth et al. Studies of cholesterol biosynthesis. 1. A new chemical degradation of cholesterol
Beroza et al. The Synthesis of dl-Sesamin and dl-Asarinin1
SU749364A3 (ru) Способ получени лактонов
Carre et al. Arynic condensation of ketone enolates. 16. Efficient access to a new series of benzocyclobutenols
NO762107L (xx)
Strekowski et al. Resolution and assignment of absolute configuration to the enantiomers of anastrephin and epianastrephin and their analogs
JPH0285273A (ja) キラル原子を有機残基中に含む新規なエーテルを使用するアルコール類、フェノール類又はラクトン構造を持つ化合物の分割方法
SU430543A1 (ru) Способ получения алкиловых эфиров3-
US3883659A (en) 9-Oxaprostaglandin compositions
SU676170A3 (ru) Способ получени 7-оксиэстрадиолов
Nakahara et al. Diterpenoid Total Synthesis Part XVI. Alternative Synthetic Routes to (±)-Steviol and (±)-Kaur-16-en-19-oic Acid
JPS609035B2 (ja) ビシクロオクタン誘導体の製造法
US2793233A (en) Hormone intermediate and production thereof
US3925392A (en) Process for preparing vincamine and its stereoisomers
Hashimoto et al. Microbiological degradation of bile acids. Metabolites formed from 3-(3a α-hexahydro-7a β-methyl-1, 5-dioxoindan-4 α-yl) propionic acid by Streptomyces rubescens
SU626706A3 (ru) Способ получени -гомостероидов
HU199768B (en) Process for production of 3,5-dihydroxi-carbonic acid and its derivatives and medical compositions containing them
US2843603A (en) 2-methyl-2-carboxymethylcyclopentanol-3-carboxylic acid lactone and preparation thereof
Sisido et al. A Synthesis of Iridomyrmecin
Takaiwa et al. Synthesis and absolute configuration of natural gregatin B
Takahashi et al. Total Synthesis of (+)-Methyl Phaseates
US4001251A (en) Apovincaldehyde
US5191125A (en) Procedure for the preparation of bicyclo [3.2.0]hept-2-en-7-ones
RU2190622C1 (ru) Способ получения бетулиновой кислоты
Walker Podophyllotoxin Studies. A Synthesis of the Carbon—Oxygen Skeleton